This process is supported by transmembrane protease serine 2 (TMPRSS2) (14), which in COVID-19 leads to a robust immune response resulting in acute inflammation with increased levels of inflammatory mediators including cytokines and chemokines (15). The gene discussed is TMPRSS2; the disease is COVID-19.